SFBC International 1Q Revenues: $110 million (+14%) 1Q Loss: $4 million* (earnings were $5 million 1Q2005) Comments: Early Clinical Development segment revenues were approximately $33 million, or 41% of total revenues, down 20%. The loss from operations for Early Clinical Development was approximately $5.6 million, representing a (17.0)% operating margin on revenue. Late Clinical Development segment revenues were approximately $47 million, or 59% of total revenue, up 31%. Earnings f...